Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sparsh Biotech is a progressive, quality-conscious pharmaceutical formulation manufacturer based in Jamnagar, Gujarat, India. Established in 2001, the company operates a 100% export-oriented manufacturing facility featuring dedicated beta-lactam and cephalosporin plants. Sparsh Biotech specializes in producing a wide range of generic antibiotic dosage forms, including capsules, tablets, and dry syrups, under brand names such as Spamox, Spamcil, and Cloxispa. The company has a commercial presence in over 50 countries across Africa, Europe, and the Americas, and also provides contract manufacturing services for major pharmaceutical companies like Zydus Cadila and Torrent Pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sparsh Biotech.